glp-1 drugs for obesity New Guidelines on Released GLP-1 Drugs for Weight Loss:

As of 2022, GLP-1RAs have been recommended as first-line treatments, along with SGLT-2 inhibitors, for patients with T2DM and cardiovascular disease in American Diabetes Associations Standards of Medical Care in Diabetes (248, 249)

For a holisitc view of the treatment landscape for MASH, our clinical insights white paper, Metabolic dysfunction-associated steatohepatitis (MASH) A new era in liver health, provides a comprehensive look at emerging approaches to liver care

Our hope is that research on both berberine and Ozempic will be published showing successful DEXA scans that maintain muscle tissue with high-protein diets, and when that's the case, we'll be a bit more confident in the more aggressive interventions

A growing body of evidence highlights their significant benefits for overall health

This support system fosters accountability and encourages long-term adherence to treatment plans

The weight-loss magic of Gila monster venom The Gila monster is a large lizard native to the deserts of the American Southwest and northern Mexico